Single-Use Technology in Biopharmaceutical Manufacture | Agenda Bookshop Skip to content

Biopharmaceutical manufacture

Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Dieter Eibl
B01=Regine Eibl
Category1=Non-Fiction
Category=PS
Category=TDC
Category=TDCB
COP=United States
Delivery_Delivery within 10-20 working days
development of biopharmaceutical products
disposable bioreactor systems
eq_isMigrated=2
eq_non-fiction
eq_science
eq_tech-engineering
Language_English
PA=Available
Price_€100 and above
PS=Active
single-use biopharmaceutical products
single-use bioreactors
single-use immune cell therapeutics

single-use technologies cell therapy
softlaunch

Single-Use Technology in Biopharmaceutical Manufacture

English

Authoritative guide to the principles, characteristics, engineering aspects, economics, and applications of disposables in the manufacture of biopharmaceuticals

The revised and updated second edition of Single-Use Technology in Biopharmaceutical Manufacture offers a comprehensive examination of the most-commonly used disposables in the manufacture of biopharmaceuticals. The authors—noted experts on the topic—provide the essential information on the principles, characteristics, engineering aspects, economics, and applications.

This authoritative guide contains the basic knowledge and information about disposable equipment. The author also discusses biopharmaceuticals’ applications through the lens of case studies that clearly illustrate the role of manufacturing, quality assurance, and environmental influences. This updated second edition revises existing information with recent developments that have taken place since the first edition was published. The book also presents the latest advances in the field of single-use technology and explores topics including applying single-use devices for microorganisms, human mesenchymal stem cells, and T-cells. This important book:

•    Contains an updated and end-to-end view of the development and manufacturing of single-use biologics

•    Helps in the identification of appropriate disposables and relevant vendors

•    Offers illustrative case studies that examine manufacturing, quality assurance, and environmental influences

•    Includes updated coverage on cross-functional/transversal dependencies, significant improvements made by suppliers, and the successful application of the single-use technologies

Written for biopharmaceutical manufacturers, process developers, and biological and chemical engineers, Single-Use Technology in Biopharmaceutical Manufacture, 2nd Edition provides the information needed for professionals to come to an easier decision for or against disposable alternatives and to choose the appropriate system.

See more
€183.46

Biopharmaceutical manufactureAge Group_Uncategorizedautomatic-updateB01=Dieter EiblB01=Regine EiblCategory1=Non-FictionCategory=PSCategory=TDCCategory=TDCBCOP=United StatesDelivery_Delivery within 10-20 working daysdevelopment of biopharmaceutical productsdisposable bioreactor systemseq_isMigrated=2eq_non-fictioneq_scienceeq_tech-engineeringLanguage_EnglishPA=AvailablePrice_€100 and abovePS=Activesingle-use biopharmaceutical productssingle-use bioreactorssingle-use immune cell therapeutics

single-use technologies cell therapysoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 1247g
  • Dimensions: 221 x 282mm
  • Publication Date: 01 Nov 2019
  • Publisher: John Wiley & Sons Inc
  • Publication City/Country: US
  • Language: English
  • ISBN13: 9781119477839

About

REGINE EIBL, PHD, is a professor at the Zurich University of Applied Sciences (Switzerland), where she lectures in biotechnology and cell cultivation techniques.

DIETER EIBL, PHD, is a professor at the Zurich University of Applied Sciences, where he lectures in biochemical engineering and the planning of biotechnological production facilities.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept